Macfarlane Group (LSE:MACF), the UK's largest distributor of protective packaging, dropped to around 65p on the session, off close to 4% and back near the bottom of a 52-week range that stretches up to 120p. The slide came even as the company keeps buying back its own shares, with weekly Transaction in Own Shares notices running through June, July and into August 2026. A notice of results on 6 August points to interim figures landing shortly, and a defined-benefit pension buy-in on 30 June has de-risked the balance sheet. With last year's statutory profit sharply lower even as sales grew, investors are wrestling with whether the buyback signals confidence or simply cushions a stock the market has fallen out of love with. Here is what the numbers say and where the debate goes next.
What happened?
Macfarlane shares fell to about 65p, a drop of roughly 3.7% on the day, leaving them close to the low end of a 52-week range that runs from just under 60p up to 120p. The decline is notable because it comes despite a steady, well-signposted programme of share buybacks: the company has published Transaction in Own Shares notices on a near-weekly cadence, including on 10 August, 3 August, 27 July, 20 July, 13 July, 6 July and 29 June 2026.
There was no profit warning attached to the move. Instead, the weakness looks like a continuation of a year-long de-rating, with the shares having roughly halved from their 12-month peak. On 6 August the group issued a Notice of Results and investor presentation, signalling that half-year figures are imminent, and traders often turn cautious ahead of such updates.
Macfarlane also completed a defined-benefit pension scheme buy-in on 30 June, a move that removes a Long-Tail Liability but uses balance-sheet resources. The precise trigger for the session's fall is not tied to a single announcement, and appears to reflect soft sentiment toward a packaging distributor exposed to subdued industrial and E-commerce demand.
The numbers investors need to know
At around 65p, Macfarlane is valued at roughly £105m. The shares are down about 46% from their 52-week high of 120p, a steep fall for a Business that remains solidly revenue-generative.
The last reported full year showed sales of about £300.8m, up around 11% and helped by acquisitions, but the profit picture was weaker. Adjusted pre-tax profit came in near £15.6m, lower year on year, while adjusted Earnings Per Share eased to about 7.62p. On a statutory basis the contrast was starker still, with Net Income of roughly £6.3m, down close to 60% as higher costs, Amortisation and one-off items bit into reported earnings.
The ongoing buyback is the counterweight the bulls point to. By steadily retiring shares, Macfarlane is returning cash and supporting per-share metrics, and analyst price targets have clustered well above the current level, implying meaningful upside if trading stabilises. Even so, the buyback has not been enough to arrest the share-price slide.
Why the market may be concerned
The headline worry is the gap between Revenue growth and falling profit. Sales rose, but statutory net income fell sharply, a sign of Margin pressure, cost Inflation and the drag from acquisition-related and exceptional charges. Investors want to see profitability converted from the top line, not eroded beneath it.
Demand is the second concern. As a distributor of protective packaging, Macfarlane is geared to industrial output, Manufacturing activity and e-commerce volumes, all of which have been subdued. A soft macro backdrop limits the group's pricing power and Volume growth, keeping a lid on margins.
There is also the question of what a persistent buyback signals when the shares keep falling. Bears argue that repurchases can mask an absence of higher-return growth opportunities, and that cash deployed on Buybacks and a pension buy-in is cash not spent on expansion. With the stock near 52-week lows, the market is clearly not yet convinced.
Why bulls may see an opportunity
For the optimists, Macfarlane offers a market-leading position, growing sales and a management team returning cash through both dividends and buybacks. Trading on a modest multiple after a near-halving of the share price, the stock looks cheap relative to its history and to the analyst price targets that sit well above the current level.
The pension buy-in, while consuming resources, removes a significant source of long-term uncertainty and volatility, arguably making the Equity easier to value. A cleaner Balance Sheet and reduced liability risk can support a higher rating over time.
The buyback itself is accretive at depressed prices. Every share retired at around 65p lifts future earnings and dividends per share, and if the interim results due shortly show resilient margins or a Demand recovery, the combination of cheap valuation and shrinking share count could drive a rapid re-rating.
What happens next?
The immediate catalyst is the half-year results flagged by the 6 August notice. Investors will focus on whether adjusted margins are holding, how volumes are trending across industrial and e-commerce packaging, and what management says about the demand outlook for the second half.
The pace and scale of the buyback will also be watched, as will the dividend, which underpins the income case. Any commentary on Acquisition appetite matters too, given Macfarlane's record of bolt-on deals to consolidate a fragmented distribution market. The near-weekly buyback notices through the summer suggest the programme will continue alongside the results.
Beyond the results, the read-across from wider industrial and consumer activity will shape sentiment. Evidence that manufacturing and online retail volumes are stabilising would help, while further softness would keep pressure on a stock the market has already marked down heavily.
Bottom line
Macfarlane's drop to around 65p, near the bottom of a 60p-to-120p range, shows that a consistent buyback has not been enough to offset weak sentiment toward a packaging distributor facing soft demand and squeezed profits. Sales are still growing, but statutory net income fell close to 60% last year, and the shares have roughly halved from their peak. The imminent interim results are the key test: resilient margins and a steadier demand backdrop could reward patient holders, given a modest valuation, a supportive buyback and analyst targets well above today's price. Fail to reassure, and the market's scepticism about returning cash while the shares slide will only harden. For now, Macfarlane is a value-and-income candidate still waiting for a catalyst to change the narrative.






Please wait processing your request...